Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine if the administration of a single dose of oral
ondansetron (an anti-vomiting medication), compared to placebo, results in a reduction in
intravenous (IV) rehydration therapy in children presenting for emergency department care
with some dehydration, vomiting and diarrhea in Pakistan.
SOME Dehydration is defined as 2 or more of the following signs and symptoms:
- Restlessness, irritability
- Sunken Eyes
- Drinks eagerly, thirsty
- Skin pinch goes back slowly
Phase:
Phase 4
Details
Lead Sponsor:
Dr. Stephen Freedman Sarah Williamson-Urquhart
Collaborators:
Aga Khan University Bill and Melinda Gates Foundation Thrasher Research Fund